Emerenziana Ottaviano

Milan, 20142, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Roseburia-Associated Gut-Brain Axis Alterations in Relapsing-Remitting Multiple Sclerosis: Evidence from a Household-Matched Case-Control Study.

Roseburia-Associated Gut-Brain Axis Alterations in Relapsing-Remitting Multiple Sclerosis: Evidence from a Household-Matched Case-Control Study.

Journal: Nutrients

Published: February 04, 2026

Roseburia-Associated Gut-Brain Axis Alterations in Relapsing-Remitting Multiple Sclerosis: Evidence from a Household-Matched Case-Control Study.

Roseburia-Associated Gut-Brain Axis Alterations in Relapsing-Remitting Multiple Sclerosis: Evidence from a Household-Matched Case-Control Study.

Journal: Nutrients

Published: February 04, 2026

Correction: Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study.

Correction: Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study.

Journal: Frontiers in neuroscience

Published: December 04, 2025

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study.

Gut Microbiota and Metabolic Modulation by Slow-Release Protein Substitutes in Phenylketonuria: Findings from the PREMP Study.

Journal: Nutrients

Published: November 10, 2025

Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study.

Gut microbiota signatures in tuberous sclerosis complex and epilepsy: a pilot study.

Journal: Frontiers in neuroscience

Published: June 27, 2025

Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial.

Targeting the gut to improve seizure control in CDKL5 deficiency disorder (CDD): study protocol for a single-arm, open-label clinical trial.

Journal: Frontiers in neurology

Published: June 06, 2025

Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content.

Pilocarpine inhibits Candida albicans SC5314 biofilm maturation by altering lipid, sphingolipid, and protein content.

Journal: Microbiology spectrum

Published: March 20, 2025

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients.

Effectiveness of Anti-SARS-CoV-2 monoclonal antibodies in real-life: RNAemia and clinical outcomes in high-risk COVID-19 patients.

Journal: PloS one

Published: September 03, 2024

Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study).

Effect of docosahexaenoic acid as an anti-inflammatory for Caco-2 cells and modulating agent for gut microbiota in children with obesity (the DAMOCLE study).

Journal: Journal of endocrinological investigation

Published: February 28, 2024

Gut microbiota profile in CDKL5 deficiency disorder patients.

Gut microbiota profile in CDKL5 deficiency disorder patients.

Journal: Scientific reports

Published: December 01, 2023

Synthesis of amphiphilic hydantoin-based universal peptidomimetics as antibiotic agents.

Synthesis of amphiphilic hydantoin-based universal peptidomimetics as antibiotic agents.

Journal: Organic & biomolecular chemistry

Published: September 12, 2023

Preschool-located influenza vaccination and influenza-like illness surveillance: an Italian pilot experience.

Preschool-located influenza vaccination and influenza-like illness surveillance: an Italian pilot experience.

Journal: Italian journal of pediatrics

Published: May 10, 2023

Showing 1-12 of 33

Last Updated: 09/26/2026